Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CRH PLC T.CRH


Primary Symbol: CRH

CRH PLC is a provider of building materials solutions. The Company integrates building materials, products, and services by providing them to customers as complete solutions. Its segments include Americas Materials Solutions, Americas Building Solutions, Europe Materials Solutions and Europe Building Solutions. The Americas Materials Solutions segment provides solutions for the construction and maintenance of public infrastructure and commercial and residential buildings in North America. The Americas Building Solutions segment manufactures, supplies, and delivers solutions for the built environment in communities across North America. The Europe Materials Solutions segment provides solutions for the construction of public infrastructure and commercial and residential buildings to customers in construction markets in Europe. The Europe Building Solutions segment combines materials, products, and services to produce a range of architectural and infrastructural solutions.


NYSE:CRH - Post by User

Post by WINDGOD46on Mar 17, 2018 7:45pm
126 Views
Post# 27734660

company's strategy is correct

company's strategy is correctIt remains to be seen how the new rates will impact the company's profitability. The new rates kicked in in January. In the interim the company is committed  to buying back up to 10% of the float and untli profitability is within acceptable bounds, the buy-back strategy makes sense. If at the same time the company makes an acquisition it will improve the top and bottom line. The price of the stock is usually influenced by the forward earning expectations and to many funds the earnings visibility is not clear hence they stay out and ignore the stock. The coming quarter the company must show that despite the reduced reimbursement rates for colonoscopies it can meet revenues and margin targets. The company said that it can do it by organic growth and acquisitions. They did not specify whether the organic growth refers to the O'Regan hemorroid procedures( up to now this has come down to us as organic growth and not through the anesthisiology part of the business.) During thr cc, i did not hear any questions to clarify the "organic growth" claim. If someone has any info on this question, let us hear it. Thannks
<< Previous
Bullboard Posts
Next >>